<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IMR</journal-id>
<journal-id journal-id-type="hwp">spimr</journal-id>
<journal-title>Journal of International Medical Research</journal-title>
<issn pub-type="ppub">0300-0605</issn>
<issn pub-type="epub">1473-2300</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300060513488516</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300060513488516</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Retrospective analysis of 102 cases of solid pseudopapillary neoplasm of the pancreas in China</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Li-Jie</given-names></name>
<xref ref-type="fn" rid="fn1-0300060513488516">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bai</surname><given-names>Li</given-names></name>
<xref ref-type="fn" rid="fn1-0300060513488516">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Su</surname><given-names>Dan</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Ting-Ting</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Mao</surname><given-names>Zhi-Yuan</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Guo</surname><given-names>Xiao-Chuan</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jiao</surname><given-names>Shun-Chang</given-names></name>
<xref ref-type="corresp" rid="corresp1-0300060513488516"/>
</contrib>
</contrib-group>
<aff id="aff1-0300060513488516">Department of Oncology, Chinese People’s Liberation Army General Hospital, PLA Medical School, Beijing, China</aff>
<author-notes>
<corresp id="corresp1-0300060513488516">Dr Shun-Chang Jiao, Oncology Department, Chinese People’s Liberation Army General Hospital, PLA Medical School, Beijing 100853, China. Email: <email>dr_jiao301@126.com</email></corresp>
<fn fn-type="equal" id="fn1-0300060513488516"><p>*These authors contributed equally to this work.</p></fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>4</issue>
<fpage>1266</fpage>
<lpage>1271</lpage>
<history>
<date date-type="received"><day>14</day><month>3</month><year>2013</year></date>
<date date-type="accepted"><day>23</day><month>3</month><year>2013</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="sec9-0300060513488516"><title>Objective</title>
<p>Clinicopathological features and surgical outcomes in patients with solid pseudopapillary neoplasm (SPN) of the pancreas were analysed.</p>
</sec>
<sec id="sec10-0300060513488516"><title>Methods</title>
<p>Data regarding clinicopathological features, surgery and outcome for patients with SPN were retrospectively collected and analysed. Patients were followed-up by telephone interview.</p>
</sec>
<sec id="sec11-0300060513488516"><title>Results</title>
<p>The study included 102 patients (89 females/13 males), 99 of whom underwent surgical resection. A total of 89 patients (87.3%) were followed-up (mean duration 26.98 months, range 2–95 months); 86 (96.6%) had no relapse or metastasis.</p>
</sec>
<sec id="sec12-0300060513488516"><title>Conclusions</title>
<p>Surgical resection is the primary therapy for SPN, and results in a good prognosis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Solid pseudopapillary neoplasm</kwd>
<kwd>pancreas</kwd>
<kwd>surgical resection</kwd>
<kwd>prognosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0300060513488516" sec-type="intro"><title>Introduction</title>
<p>Solid pseudopapillary neoplasm (SPN) is defined by the World Health Organization as a pancreatic tumour with undetermined borderline or malignant potential and uncertain origin,<sup><xref ref-type="bibr" rid="bibr1-0300060513488516">1</xref></sup> with an incidence of 1–3% of all pancreatic tumours.<sup><xref ref-type="bibr" rid="bibr1-0300060513488516">1</xref><xref ref-type="bibr" rid="bibr2-0300060513488516"/><xref ref-type="bibr" rid="bibr3-0300060513488516"/>–<xref ref-type="bibr" rid="bibr4-0300060513488516">4</xref></sup> Despite improvements in SPN detection, diagnosis and reporting,<sup><xref ref-type="bibr" rid="bibr4-0300060513488516">4</xref><xref ref-type="bibr" rid="bibr5-0300060513488516"/>–<xref ref-type="bibr" rid="bibr6-0300060513488516">6</xref></sup> misdiagnosis as pancreatic adenocarcinoma and lack of consensus regarding treatment remain major obstacles in disease management.<sup><xref ref-type="bibr" rid="bibr5-0300060513488516">5</xref>,<xref ref-type="bibr" rid="bibr7-0300060513488516">7</xref></sup></p>
<p>Studies have shown that SPN usually occurs in young women,<sup><xref ref-type="bibr" rid="bibr6-0300060513488516">6</xref>,<xref ref-type="bibr" rid="bibr8-0300060513488516">8</xref></sup> but clinical manifestations, pathological features and treatment modalities vary. The aim of the current study, therefore, was to analyse the clinicopathological characteristics and treatment outcomes of patients with SPN, retrospectively.</p>
</sec>
<sec id="sec2-0300060513488516" sec-type="methods"><title>Patients and methods</title>
<sec id="sec3-0300060513488516"><title>Study population</title>
<p>This retrospective analysis included all patients with pathologically confirmed SPN<sup><xref ref-type="bibr" rid="bibr9-0300060513488516">9</xref></sup> admitted to the Department of Oncology, Chinese People’s Liberation Army General Hospital, Beijing, China, between October 2001 and June 2010. Clinicopathological and treatment data were extracted from clinical records. Patients were followed-up at regular intervals by telephone interview until September 2010.</p>
<p>The Ethics Committee of the Chinese People’s Liberation Army General Hospital, Beijing, China approved the study, and all patients provided written informed consent prior to enrolment.</p>
</sec>
<sec id="sec4-0300060513488516"><title>Immunohistochemistry</title>
<p>Immunohistochemical analysis of tumour tissue was performed using a streptavidin peroxidise-conjugated method,<sup><xref ref-type="bibr" rid="bibr10-0300060513488516">10</xref></sup> using antibodies to chromogranin A, synaptophysin, neural endopeptidase (CD10), neural cell adhesion molecule (CD56), glucagon, vimentin and insulin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immunohistochemical staining was analysed by two independent pathologists (L.J.W. and L.B.).</p>
</sec>
</sec>
<sec id="sec5-0300060513488516" sec-type="results"><title>Results</title>
<p>The study included 102 patients with SPN (13 males/89 females; ratio 1 : 6.85); mean age 42.9 ± 14.6 years in males (range: 16–71 years) and 27.3 ± 11.6 years in females (range: 9–52 years).</p>
<p>Peak incidence of SPN occurred at 10–19 years of age in females and at 30–39 and 50–59-years-old in males (<xref ref-type="table" rid="table1-0300060513488516">Table 1</xref>).
<table-wrap id="table1-0300060513488516" position="float"><label>Table 1.</label><caption><p>Age distribution of Chinese patients with solid pseudopapillary neoplasm of the pancreas, stratified according to sex (<italic>n</italic> = 102).</p></caption>
<graphic alternate-form-of="table1-0300060513488516" xlink:href="10.1177_0300060513488516-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Age range, years</th>
<th>Female <italic>n</italic> = 89</th>
<th>Male <italic>n</italic> = 13</th>
</tr></thead>
<tbody align="left">
<tr>
<td>0–9</td>
<td>1 (1.1)</td>
<td>0 (0.0)</td>
</tr>
<tr>
<td>10–19</td>
<td>31 (34.8)</td>
<td>1 (7.7)</td>
</tr>
<tr>
<td>20–29</td>
<td>19 (21.3)</td>
<td>1 (7.7)</td>
</tr>
<tr>
<td>30–39</td>
<td>23 (25.8)</td>
<td>4 (30.8)</td>
</tr>
<tr>
<td>40–49</td>
<td>13 (14.6)</td>
<td>2 (15.4)</td>
</tr>
<tr>
<td>50–59</td>
<td>2 (2.2)</td>
<td>4 (30.8)</td>
</tr>
<tr>
<td>60–69</td>
<td>0 (0.0)</td>
<td>0 (0.0)</td>
</tr>
<tr>
<td>70–79</td>
<td>0 (0.0)</td>
<td>1 (7.7)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300060513488516"><p>Data presented as <italic>n</italic> (%).</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Clinical and pathological characteristics of patients with SPN are shown in <xref ref-type="table" rid="table2-0300060513488516">Table 2</xref>. In terms of presentation, 50% (51/102) of patients were asymptomatic and 45% (46/102) presented with abdominal pain or discomfort. None of the patients had any history of pancreatitis, one had a history of abdominal trauma and two had a history of diabetes mellitus. Abnormal liver function (elevated aminotransferase or total bilirubin) was detected in &lt;5% of patients (<xref ref-type="table" rid="table2-0300060513488516">Table 2</xref>). A total of 13 (13%) patients had elevated serum tumour markers, including α-fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigens (CA) 125, 199 and 724, and neuron specific enolase (NSE). Elevated CA125, CA199, CA724, NSE, CEA and AFP were observed in three, two, two, one, one and one case(s), respectively.
<table-wrap id="table2-0300060513488516" position="float"><label>Table 2.</label><caption><p>Clinical and pathological features of Chinese patients with solid pseudopapillary neoplasm of the pancreas.</p></caption>
<graphic alternate-form-of="table2-0300060513488516" xlink:href="10.1177_0300060513488516-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Feature</th>
<th>Female <italic>n</italic> = 89</th>
<th>Male <italic>n</italic> = 13</th>
<th>Total <italic>n</italic> = 102</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Age, years</td>
<td>27 (9–52)</td>
<td>43 (16–71)</td>
<td>29 (9–71)</td>
</tr>
<tr>
<td colspan="4">Presenting symptoms and signs</td>
</tr>
<tr>
<td> None</td>
<td>46 (51.7)</td>
<td>5 (38.5)</td>
<td>51 (50.0)</td>
</tr>
<tr>
<td> Abdominal pain/discomfort</td>
<td>43 (48.3)</td>
<td>3 (23.1)</td>
<td>46 (45.1)</td>
</tr>
<tr>
<td> Diarrhoea</td>
<td>0 (0.0)</td>
<td>2 (15.4)</td>
<td>2 (2.0)</td>
</tr>
<tr>
<td> Weight loss, range 2 – 20 kg</td>
<td>11 (12.4)</td>
<td>2 (15.4)</td>
<td>13 (12.7)</td>
</tr>
<tr>
<td> Physical examination findings</td>
<td>15 (16.9)</td>
<td>3 (23.1)</td>
<td>18 (17.6)</td>
</tr>
<tr>
<td> Other<sup><xref ref-type="table-fn" rid="table-fn1-0300060513488516">a</xref></sup></td>
<td>2 (2.2)</td>
<td>1 (7.7)</td>
<td>3 (2.9)</td>
</tr>
<tr>
<td colspan="4">Postadmission examination findings</td>
</tr>
<tr>
<td> Palpable abdominal mass</td>
<td>31 (34.8)</td>
<td>1 (7.7)</td>
<td>32 (31.4)</td>
</tr>
<tr>
<td> Tenderness</td>
<td>10 (11.2)</td>
<td>3 (23.1)</td>
<td>13 (12.7)</td>
</tr>
<tr>
<td> Elevated aminotransferase</td>
<td>5 (5.6)</td>
<td>0 (0.0)</td>
<td>5 (4.9)</td>
</tr>
<tr>
<td> Elevated total bilirubin</td>
<td>3 (3.4)</td>
<td>1 (7.7)</td>
<td>4 (3.9)</td>
</tr>
<tr>
<td> Diabetes mellitus</td>
<td>1 (1.1)</td>
<td>1 (7.7)</td>
<td>2 (2.0)</td>
</tr>
<tr>
<td> Hypoglycaemia</td>
<td>1 (1.1)</td>
<td>0 (0.0)</td>
<td>1 (1.0)</td>
</tr>
<tr>
<td> Elevated serum tumour markers</td>
<td>11 (12.4)</td>
<td>2 (15.4)</td>
<td>13 (12.7)</td>
</tr>
<tr>
<td> Tumour diameter, cm</td>
<td>7 (2–18)</td>
<td>6 (2–30)</td>
<td>7 (2–30)</td>
</tr>
<tr>
<td colspan="4">Tumour location</td>
</tr>
<tr>
<td> Head</td>
<td>31 (24.8)</td>
<td>3 (23.1)</td>
<td>34 (33.3)</td>
</tr>
<tr>
<td> Neck</td>
<td>17 (19.1)</td>
<td>2 (15.4)</td>
<td>19 (18.6)</td>
</tr>
<tr>
<td> Body and tail</td>
<td>41 (46.1)</td>
<td>8 (61.5)</td>
<td>49 (48.0)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0300060513488516"><p>Data presented as mean (range) or <italic>n</italic> (%).</p></fn>
<fn id="table-fn3-0300060513488516"><label>a</label><p>Includes one case each of abnormal liver function, elevated blood pressure, and palpitations/sweating/disordered consciousness.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Diagnosis was confirmed by imaging in 31 cases (30%). An additional 12 cases (12%) were thought to be pancreatic adenocarcinomas; the remaining 59 cases (58%) could not be definitively diagnosed. Typical abdominal ultrasonography findings were of a single nonhomogeneous hypoechoic space-occupying lesion or a cystic-solid lesion of irregular shape with a clear edge in the pancreatic area, inside which the arterial and venous flow spectrum could be explored. Common bile duct expansion could be detected in some cases. Plain computed tomography examinations generally revealed round or oval low-density space-occupying lesions (<xref ref-type="fig" rid="fig1-0300060513488516">Figure 1a</xref>). Irregular enhancement was observed around the tumour edge during enhanced arterial scan, even in the absence of obvious intermediate enhancement. A few tumours were surrounded by punctate calcification. Magnetic resonance imaging identified a variety of tissue structures inside the tumour. Slight enhancement was observed during the arterial phase. Solid tumours gradually strengthened and cystic tumours were insignificantly enhanced during the portal venous and delayed phases (<xref ref-type="fig" rid="fig1-0300060513488516">Figure 1b</xref>).
<fig id="fig1-0300060513488516" position="float"><label>Figure 1.</label><caption><p>Cross-sectional imaging of a solid pseudopapillary tumour of the pancreas. (a) Axial computed tomography image showing round or oval low-density space-occupying lesions in the head of the pancreas (arrow). (b) Magnetic resonance image showing space-occupying lesions in the body and tail of the pancreas, and intrahepatic metastases (arrows).</p></caption><graphic xlink:href="10.1177_0300060513488516-fig1.tif"/>
</fig></p>
<p>Diagnosis was pathologically confirmed in all patients, either by puncture biopsy (three of 102 patients, 3%) or following surgery (99/102 patients, 97%). Details of surgery type and findings are shown in <xref ref-type="table" rid="table3-0300060513488516">Table 3</xref>.
<table-wrap id="table3-0300060513488516" position="float"><label>Table 3.</label><caption><p>Characteristics of surgery in Chinese patients with solid pseudopapillary neoplasm of the pancreas.</p></caption>
<graphic alternate-form-of="table3-0300060513488516" xlink:href="10.1177_0300060513488516-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Characteristic</th>
<th>Total <italic>n</italic> = 99</th>
</tr></thead>
<tbody align="left">
<tr>
<td colspan="2">Surgery type</td>
</tr>
<tr>
<td> Simple resection</td>
<td>29 (29.3)</td>
</tr>
<tr>
<td> Pancreaticoduodenectomy<sup><xref ref-type="table-fn" rid="table-fn2-0300060513488516">a</xref></sup></td>
<td>15 (15.2)</td>
</tr>
<tr>
<td> Resection and pancreaticojejunostomy</td>
<td>11 (11.1)</td>
</tr>
<tr>
<td> Distal pancreatectomy</td>
<td>26 (26.3)</td>
</tr>
<tr>
<td> Distal pancreatectomy and splenectomy</td>
<td>16 (16.2)</td>
</tr>
<tr>
<td> Pylorus-preserving pancreaticoduodenectomy with   resection of hepatic metastasis</td>
<td>1 (1.0)</td>
</tr>
<tr>
<td> Exploratory surgery</td>
<td>1 (1.0)</td>
</tr>
<tr>
<td colspan="2">Surgical findings</td>
</tr>
<tr>
<td> No adhesion</td>
<td>41 (41.4)</td>
</tr>
<tr>
<td> Obvious adhesion</td>
<td>58 (58.6)</td>
</tr>
<tr>
<td> Bile duct dilation</td>
<td>9 (9.1)</td>
</tr>
<tr>
<td> Liver metastasis</td>
<td>1 (1.0)</td>
</tr>
<tr>
<td> Lymphatic metastasis</td>
<td>1 (1.0)</td>
</tr>
<tr>
<td>Number of tumours</td>
</tr>
<tr>
<td> One</td>
<td>98 (99.0)</td>
</tr>
<tr>
<td> Multiple</td>
<td>1 (1.0)</td>
</tr>
<tr>
<td> Metastatic</td>
<td>3 (3.0)</td>
</tr>
<tr>
<td colspan="2">Postoperative complications<sup><xref ref-type="table-fn" rid="table-fn3-0300060513488516">b</xref></sup></td>
</tr>
<tr>
<td> None</td>
<td>66 (66.7)</td>
</tr>
<tr>
<td> Pancreatic fistula</td>
<td>16 (16.2)</td>
</tr>
<tr>
<td> Elevated platelets following splenectomy</td>
<td>16 (16.2)</td>
</tr>
<tr>
<td> Gastrointestinal bleeding</td>
<td>1 (1.0)</td>
</tr>
<tr>
<td> Pleural effusion</td>
<td>1 (1.0)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0300060513488516"><p>Data presented as <italic>n</italic> (%).</p></fn>
<fn id="table-fn5-0300060513488516"><label>a</label><p>Includes five cases of pylorus-preserving pancreaticoduodenectomy.</p></fn>
<fn id="table-fn6-0300060513488516"><label>b</label><p>Adequately controlled by symptomatic treatment.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>A total of 89 patients (87%) were followed-up, for a mean of 27 months (range 2–95 months, median 22 months). Of these patients, 86 (97%) had no relapse or metastasis. Three patients died: one due to relapse and metastasis, one due to acute pulmonary embolism, and one (who did not undergo surgical resection) due to advanced disease progression. A single patient with hepatic, pulmonary and retroperitoneal lymphatic metastases received two cycles of gemcitabine + cisplatin + anti-EGFR antibody. Disease progression was reassessed and the chemotherapy regimen was changed to paclitaxel + carboplatin + anti-EGFR antibody. During chemotherapy, the patient had abdominal and lumbosacral pain, refused to continue chemotherapy, and was transferred to a local hospital for radiotherapy.</p>
<p>Immunohistochemical staining data were available for 91 patients (<xref ref-type="table" rid="table4-0300060513488516">Table 4</xref>). High numbers of cases were positive for synaptophysin, vimentin, CD10 and CD56, while the majority were negative for chromogranin A, insulin and glucagon.
<table-wrap id="table4-0300060513488516" position="float"><label>Table 4.</label><caption><p>Immunohistochemical findings of tumour tissue samples from 91 Chinese patients with solid pseudopapillary neoplasm of the pancreas.</p></caption>
<graphic alternate-form-of="table4-0300060513488516" xlink:href="10.1177_0300060513488516-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Antigen</th>
<th><italic>n</italic></th>
<th>Positive cases, <italic>n</italic></th>
<th>Positive rate, %</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Synaptophysin</td>
<td>80</td>
<td>48</td>
<td>60.0</td>
</tr>
<tr>
<td>CD10</td>
<td>82</td>
<td>61</td>
<td>74.4</td>
</tr>
<tr>
<td>CD56</td>
<td>71</td>
<td>67</td>
<td>94.4</td>
</tr>
<tr>
<td>Vimentin</td>
<td>41</td>
<td>35</td>
<td>85.4</td>
</tr>
<tr>
<td>Glucagon</td>
<td>16</td>
<td>2</td>
<td>12.5</td>
</tr>
<tr>
<td>Insulin</td>
<td>32</td>
<td>2</td>
<td>6.3</td>
</tr>
<tr>
<td>Chromogranin A</td>
<td>79</td>
<td>8</td>
<td>10.1</td>
</tr>
</tbody>
</table>
</table-wrap></p>
</sec>
<sec id="sec6-0300060513488516" sec-type="discussion"><title>Discussion</title>
<p>This retrospective analysis of patients with SPN revealed that the majority were young women, with a gender ratio of 6.85 : 1 and a mean age of 29 years, which are higher rates than those reported by others.<sup><xref ref-type="bibr" rid="bibr6-0300060513488516">6</xref><xref ref-type="bibr" rid="bibr7-0300060513488516"/>–<xref ref-type="bibr" rid="bibr8-0300060513488516">8</xref>,<xref ref-type="bibr" rid="bibr11-0300060513488516">11</xref></sup> In accordance with other findings, 50% of the current patients were asymptomatic at presentation, while others presented with diarrhoea and abdominal pain, distension or masses.<sup><xref ref-type="bibr" rid="bibr12-0300060513488516">12</xref>,<xref ref-type="bibr" rid="bibr13-0300060513488516">13</xref></sup> Since abdominal discomfort and pain are qualitative parameters, useful SPN markers are required.</p>
<p>Imaging is of limited value in the diagnosis of SPN because of the difficulty in distinguishing these from cystic or solid tumours.<sup><xref ref-type="bibr" rid="bibr9-0300060513488516">9</xref></sup> The majority (58%) of patients in the current study could not be diagnosed by imaging alone, although this rate was lower than that reported elsewhere (80–90%).<sup><xref ref-type="bibr" rid="bibr14-0300060513488516">14</xref></sup> In addition, abnormal liver function and elevated serum tumour markers did not allow definitive diagnosis of SPN in the current study.</p>
<p>Over 50% of the patients in the current study were found to have obvious tumour adhesion to surrounding tissues (mainly the spleen, duodenum, colon, stomach, greater omentum, bile duct, left kidney and liver) and three patients had metastatic disease. This finding is in accordance with other research<sup><xref ref-type="bibr" rid="bibr15-0300060513488516">15</xref></sup> that SPN has high malignant potential, necessitating further investigation. A high percentage of tumours expressed CD56 and vimentin, but this may be simply representative of the diversity of exocrine, endocrine and epithelial origin of SPN.<sup><xref ref-type="bibr" rid="bibr12-0300060513488516">12</xref></sup></p>
<p>The optimal treatment of SPN is surgical resection.<sup><xref ref-type="bibr" rid="bibr16-0300060513488516">16</xref></sup> The present study included a variety of surgical procedures (including simple resection, distal pancreatectomy, pancreaticoduodenectomy and tumour resection with pancreaticojejunostomy) that were selected according to the tumour site. Due to the anatomical location of the pancreas and the tendency of tumour cells to invade major blood vessels of the abdominal cavity, SPN surgery should include resection and reconstruction of the portal vein or peripancreatic artery.<sup><xref ref-type="bibr" rid="bibr17-0300060513488516">17</xref>,<xref ref-type="bibr" rid="bibr18-0300060513488516">18</xref></sup> Repeat surgery or metastasis resection can significantly prolong survival in cases of recurrence.<sup><xref ref-type="bibr" rid="bibr9-0300060513488516">9</xref></sup></p>
<p>There is no evidence demonstrating a positive effect of postoperative adjuvant chemotherapy on prognosis of SPN.<sup><xref ref-type="bibr" rid="bibr19-0300060513488516">19</xref><xref ref-type="bibr" rid="bibr20-0300060513488516"/><xref ref-type="bibr" rid="bibr21-0300060513488516"/>–<xref ref-type="bibr" rid="bibr22-0300060513488516">22</xref></sup> Further studies are required to investigate the benefits, if any, of postoperative neoadjuvant therapy on prognosis in SPN.</p>
<p>In conclusion, the primary therapy for SPN is surgical resection, and this results in a good prognosis for patients.</p>
</sec>
</body>
<back>
<sec id="sec7-0300060513488516"><title>Declaration of conflicting interest</title>
<p>The authors declare that there is no conflict of interest.</p>
</sec>
<sec id="sec8-0300060513488516"><title>Funding</title>
<p>This work was supported by the Beijing Medicine Research and Development Fund for independent innovation and promotion of the popularization of project (2007-3048).</p>
</sec>
<ref-list><title>References</title>
<ref id="bibr1-0300060513488516"><label>1</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Kloppel</surname><given-names>G</given-names></name><name><surname>Solcia</surname><given-names>E</given-names></name><name><surname>Longnecker</surname><given-names>DS</given-names></name><etal/></person-group>. <article-title>Histological typing of tumours of the exocrine pancreas</article-title>. <source>In: World Health Organization International Classification of Tumors</source>, <edition>2nd ed</edition>. <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name>, <year>1996</year>, pp. <fpage>11</fpage>–<lpage>20</lpage>.</citation></ref>
<ref id="bibr2-0300060513488516"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexandrescu</surname><given-names>DT</given-names></name><name><surname>O'Boyle</surname><given-names>K</given-names></name><name><surname>Feliz</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Metastatic solid-pseudopapillary tumor of the pancreas: clinico-biological correlates and management</article-title>. <source>Clin Oncol (R Coll Radiol)</source> <year>2005</year>; <volume>17</volume>: <fpage>358</fpage>–<lpage>363</lpage>.</citation></ref>
<ref id="bibr3-0300060513488516"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Qahtani</surname><given-names>S</given-names></name><name><surname>Gudinchet</surname><given-names>F</given-names></name><name><surname>Laswed</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Solid pseudopapillary tumor of the pancreas in children: typical radiological findings and pathological correlation</article-title>. <source>Clin Imaging</source> <year>2010</year>; <volume>34</volume>: <fpage>152</fpage>–<lpage>156</lpage>.</citation></ref>
<ref id="bibr4-0300060513488516"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Clinical strategy for the management of solid pseudopapillary tumor of the pancreas: aggressive or less?</article-title>. <source>Int J Med Sci</source> <year>2010</year>; <volume>7</volume>: <fpage>309</fpage>–<lpage>313</lpage>.</citation></ref>
<ref id="bibr5-0300060513488516"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>DF</given-names></name><name><surname>Peng</surname><given-names>CH</given-names></name><name><surname>Zhou</surname><given-names>GW</given-names></name><etal/></person-group>. <article-title>Clinical misdiagnosis of solid pseudopapillary tumor of pancreas</article-title>. <source>Chin Med J (Engl)</source> <year>2005</year>; <volume>118</volume>: <fpage>922</fpage>–<lpage>926</lpage>.</citation></ref>
<ref id="bibr6-0300060513488516"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>BE</given-names></name></person-group>. <article-title>2nd. Solid and papillary epithelial neoplasm of the pancreas, diagnosis by cytology</article-title>. <source>South Med J</source> <year>1998</year>; <volume>91</volume>: <fpage>973</fpage>–<lpage>977</lpage>.</citation></ref>
<ref id="bibr7-0300060513488516"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dovigo</surname><given-names>AG</given-names></name><name><surname>Díaz</surname><given-names>MB</given-names></name><name><surname>Gütierrez</surname><given-names>MG</given-names></name><etal/></person-group>. <article-title>Liver transplantation as treatment in a massive metastasis from Gruber-Frantz pancreatic tumor: a case report</article-title>. <source>Transplant Proc</source> <year>2011</year>; <volume>43</volume>: <fpage>2272</fpage>–<lpage>2273</lpage>.</citation></ref>
<ref id="bibr8-0300060513488516"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>CM</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Choi</surname><given-names>JS</given-names></name><etal/></person-group>. <article-title>Solid pseudopapillary tumor of the pancreas suggesting malignant potential</article-title>. <source>Pancreas</source> <year>2006</year>; <volume>32</volume>: <fpage>276</fpage>–<lpage>280</lpage>.</citation></ref>
<ref id="bibr9-0300060513488516"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>BK</given-names></name><name><surname>Tan</surname><given-names>YM</given-names></name><name><surname>Cheow</surname><given-names>PC</given-names></name><etal/></person-group>. <article-title>Solid pseudopapillary neoplasms of the pancreas: an updated experience</article-title>. <source>J Surg Oncol</source> <year>2007</year>; <volume>95</volume>: <fpage>640</fpage>–<lpage>644</lpage>.</citation></ref>
<ref id="bibr10-0300060513488516"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kloppel</surname><given-names>G</given-names></name><name><surname>Heitz</surname><given-names>PU</given-names></name><name><surname>Capella</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions</article-title>. <source>World J Surg</source> <year>1996</year>; <volume>20</volume>: <fpage>132</fpage>–<lpage>141</lpage>.</citation></ref>
<ref id="bibr11-0300060513488516"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maffuz</surname><given-names>A</given-names></name><name><surname>Bustamante Fde</surname><given-names>T</given-names></name><name><surname>Silva</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Preoperative gemcitabine for unresectable, solid pseudopapillary tumor of the pancreas</article-title>. <source>Lancet Oncol</source> <year>2005</year>; <volume>6</volume>: <fpage>185</fpage>–<lpage>186</lpage>.</citation></ref>
<ref id="bibr12-0300060513488516"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>RC</given-names></name><name><surname>Klimstra</surname><given-names>DS</given-names></name><name><surname>Brennan</surname><given-names>MF</given-names></name><etal/></person-group>. <article-title>Solid-pseudopapillary tumor of the pancreas: a surgical enigma?</article-title>. <source>Ann Surg Oncol</source> <year>2002</year>; <volume>9</volume>: <fpage>35</fpage>–<lpage>40</lpage>.</citation></ref>
<ref id="bibr13-0300060513488516"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papavramidis</surname><given-names>T</given-names></name><name><surname>Papavramidis</surname><given-names>S</given-names></name></person-group>. <article-title>Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature</article-title>. <source>J Am Coll Surg</source> <year>2005</year>; <volume>200</volume>: <fpage>965</fpage>–<lpage>972</lpage>.</citation></ref>
<ref id="bibr14-0300060513488516"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Wolfgang</surname><given-names>CL</given-names></name></person-group>. <article-title>Solid pseudopapillary neoplasms of the pancreas</article-title>. <source>Adv Surg</source> <year>2009</year>; <volume>43</volume>: <fpage>269</fpage>–<lpage>282</lpage>.</citation></ref>
<ref id="bibr15-0300060513488516"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanada</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Invasive ductal carcinoma of the pancreas showing exophytic growth</article-title>. <source>Hepatobiliary Pancreat Dis Int</source> <year>2009</year>; <volume>8</volume>: <fpage>97</fpage>–<lpage>102</lpage>.</citation></ref>
<ref id="bibr16-0300060513488516"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarr</surname><given-names>MG</given-names></name><name><surname>Warshaw</surname><given-names>AL</given-names></name></person-group>. <article-title>Tumor versus neoplasm: Isn't it time to use the correct term–neoplasm?</article-title>. <source>Surgery</source> <year>2005</year>; <volume>137</volume>: <fpage>297</fpage>–<lpage>297</lpage>.</citation></ref>
<ref id="bibr17-0300060513488516"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soloni</surname><given-names>P</given-names></name><name><surname>Cecchetto</surname><given-names>G</given-names></name><name><surname>Dall’igna</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Management of unresectable solid papillary cystic tumor of the pancreas. A case report and literature review</article-title>. <source>J Pediatr Surg</source> <year>2010</year>; <volume>45</volume>: <fpage>e1</fpage>–<lpage>e6</lpage>.</citation></ref>
<ref id="bibr18-0300060513488516"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sumida</surname><given-names>W</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name><name><surname>Tainaka</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Liver transplantation for multiple liver metastases from solid pseudopapillary tumor of the pancreas</article-title>. <source>J Pediatr Surg</source> <year>2007</year>; <volume>42</volume>: <fpage>e27</fpage>–<lpage>e31</lpage>.</citation></ref>
<ref id="bibr19-0300060513488516"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verbeke</surname><given-names>CS</given-names></name></person-group>. <article-title>Endocrine tumours of the pancreas</article-title>. <source>Histopathology</source> <year>2010</year>; <volume>56</volume>: <fpage>669</fpage>–<lpage>682</lpage>.</citation></ref>
<ref id="bibr20-0300060513488516"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YM</given-names></name><name><surname>Zhang</surname><given-names>SH</given-names></name><name><surname>Sun</surname><given-names>CD</given-names></name><etal/></person-group>. <article-title>Diagnosis of solid pseudopapillary tumor of the pancreas: a report of 16 cases</article-title>. <source>Qilu Yixue Zazhi</source> <year>2008</year>; <volume>23</volume>: <fpage>112</fpage>–<lpage>114</lpage>.</citation></ref>
<ref id="bibr21-0300060513488516"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Washington</surname><given-names>K</given-names></name></person-group>. <article-title>Solid-pseudopapillary tumor of the pancreas: challenges presented by an unusual pancreatic neoplasm</article-title>. <source>Ann Surg Oncol</source> <year>2002</year>; <volume>9</volume>: <fpage>3</fpage>–<lpage>4</lpage>.</citation></ref>
<ref id="bibr22-0300060513488516"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>PF</given-names></name><name><surname>Hu</surname><given-names>ZH</given-names></name><name><surname>Wang</surname><given-names>XB</given-names></name><etal/></person-group>. <article-title>Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature</article-title>. <source>World J Gastroenterol</source> <year>2010</year>; <volume>16</volume>: <fpage>1209</fpage>–<lpage>1214</lpage>.</citation></ref>
</ref-list>
</back>
</article>